Minister Brodjonegoro: Indonesia Needs Vaccine Independence

Minister Brodjonegoro: Indonesia Needs Vaccine Independence

Assessment

Interactive Video

Business, Health Sciences, Biology

University

Hard

Created by

Quizizz Content

FREE Resource

The transcript discusses Indonesia's efforts to secure COVID-19 vaccines through international collaborations and domestic development. It highlights partnerships with companies like Sinovac and AstraZeneca, and the need for domestic production due to Indonesia's large and diverse population. The timeline for the domestic vaccine, Mira Puti, is outlined, along with budget considerations. The role of the private sector in vaccine distribution is also discussed, emphasizing the need for increased production capacity.

Read more

7 questions

Show all answers

1.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

Which countries has Indonesia collaborated with for COVID-19 vaccine acquisition?

Australia and Japan

United States and India

China and UAE

Brazil and Russia

2.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

How many doses of vaccine does Indonesia need to provide for its population?

100 million doses

270 million doses

1 billion doses

540 million doses

3.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

Why is Indonesia focusing on developing its own vaccine, Merah Putih?

To compete with other vaccine producers globally

To ensure vaccine independence due to its large population

To reduce costs associated with vaccine imports

To export vaccines to other countries

4.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

When is the first clinical trial for the Merah Putih vaccine expected to begin?

End of this year

Third quarter of 2021

First quarter of next year

Second quarter of next year

5.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

What is the initial budget allocated by the Indonesian government for vaccine distribution?

17 to 20 trillion rupiah

10 to 15 trillion rupiah

25 to 30 trillion rupiah

5 to 10 trillion rupiah

6.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

What is the current production capacity of Indonesia's biopharma for the COVID-19 vaccine?

300 million doses next year

100 million doses this year

250 million doses next year

500 million doses per year

7.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

What is the role of the private sector in Indonesia's vaccine production strategy?

To provide financial support for vaccine development

To conduct clinical trials

To increase production capacity beyond biopharma's limits

To export vaccines to other countries